St. Jude Credits Soaring ICD Sales To Its Product Line, Not Guidant Recall
This article was originally published in The Gray Sheet
Executive Summary
St. Jude Medical says it will continue marketing its products with the assumption that Guidant's resynchronization defibrillators (CRT-D) will return to the market by the end of the third quarter